Literature DB >> 25819188

Fractional Flow Reserve in the Transradial Era: Will Hand Vein Adenosine Infusion Suffice?: A Comparative Study of the Extent, Rapidity, and Stability of Hyperemia From Hand and Femoral Venous Routes of Adenosine Administration.

Peter Scott1, Alex Sirker2, Rafal Dworakowski2, Gideon Paul3, Luciano Candilio2, Nishat Jahagirdar2, Narbeh Melikian2, Jonathan Byrne2.   

Abstract

OBJECTIVES: The aim of this study was to assess adenosine infusion via a cannula in the back of the hand compared with central venous access to achieve peak hyperemia during fractional flow reserve (FFR).
BACKGROUND: Adenosine is often used to induce maximal hyperemia when measuring FFR. The gold standard is continuous infusion via a large central vein; however, the increasing use of the transradial route for angiography makes it desirable to have an alternative route for adenosine. Peripheral venous access is frequently obtained in the hand, but concern exists as to whether adenosine delivery from this site can achieve adequate vasodilation for accurate FFR measurement. Our aim was to address this.
METHODS: Subjects were selected from patients presenting for coronary angiography/intervention who required a pressure-wire study. Subjects received intravenous adenosine infusion sequentially via 2 routes: first, via a 20-gauge hand cannula, and then, after a washout period, via a 5- or 6-F femoral venous sheath. Adenosine was administered at 140 μg/kg/min from each site. Data interpretation was blinded. Minimal FFR achieved with intravenous adenosine from each infusion site was recorded as was the time to peak hyperemia.
RESULTS: Paired (hand and femoral adenosine) recordings taken from 84 vessels in 61 patients were suitable for blinded analysis. The mean FFR measured using adenosine administered via hand and femoral routes was 0.85 with an SD of 0.08 (intraclass correlation=0.986). Time to peak hyperemia was longer on average with hand-administered adenosine compared with femoral adenosine administration (63 s vs. 43 s; mean difference, 22 s with a 95% confidence interval: 18 s to 27 s; p<0.0001). Formal comparison of FFR stability using Mann-Whitney analysis (2 tailed) gives p=0.43, indicating no significant evidence of a difference in stability between the 2 routes.
CONCLUSIONS: Hand vein adenosine infusion produced FFR values very similar to those obtained using central femoral vein adenosine administration, with no systematic bias toward higher or lower reading from 1 site. This has important practical implications for radial access cases involving pressure-wire studies.
Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FFR; access site; adenosine; coronary intervention; fractional flow reserve

Mesh:

Substances:

Year:  2015        PMID: 25819188     DOI: 10.1016/j.jcin.2014.10.027

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  4 in total

1.  Fractional Flow Reserve: Does a Cut-off Value add Value?

Authors:  Shah R Mohdnazri; Thomas R Keeble; Andrew Sp Sharp
Journal:  Interv Cardiol       Date:  2016-05

2.  Assessment of increasing intravenous adenosine dose in fractional flow reserve.

Authors:  David Sparv; Matthias Götberg; Jan Harnek; Tobias Persson; Bjarne Madsen Hardig; David Erlinge
Journal:  BMC Cardiovasc Disord       Date:  2017-02-14       Impact factor: 2.298

3.  Comparison of hyperemic efficacy between femoral and antecubital fossa vein adenosine infusion for fractional flow reserve assessment.

Authors:  Jacek Legutko; Paweł Kleczyński; Artur Dziewierz; Lukasz Rzeszutko; Dariusz Dudek
Journal:  Postepy Kardiol Interwencyjnej       Date:  2019-03-27       Impact factor: 1.426

4.  Effect of High (200 μg/kg per Minute) Adenosine Dose Infusion on Fractional Flow Reserve Variability.

Authors:  Dimitrios Alexopoulos; Ioanna Xanthopoulou; Grigorios Tsigkas; Nikolaos Koutsogiannis; Paraskevi Salata; Stylianos Armylagos; Athanasios Moulias; Periklis Davlouros
Journal:  J Am Heart Assoc       Date:  2016-11-10       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.